WuXi Biologics (Cayman) Inc
HKEX:2269
WuXi Biologics (Cayman) Inc
HKEX:2269
Price:
12.44 HKD
-3.42%
Market Closed
Updated:
May 26, 2024
WuXi Biologics (Cayman) Inc
Operating Expenses
|
WuXi Biologics (Cayman) Inc
Operating Expenses Peer Comparison
Comparables:
603259
300759
300347
1548
M
688114
Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
WuXi Biologics (Cayman) Inc
HKEX:2269
|
Operating Expenses
-¥2.7B
|
CAGR 3-Years
-45%
|
CAGR 5-Years
-53%
|
CAGR 10-Years
N/A
|
|
|
WuXi AppTec Co Ltd
SSE:603259
|
Operating Expenses
-¥4.8B
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
N/A
|
|
|
Pharmaron Beijing Co Ltd
SZSE:300759
|
Operating Expenses
-¥2.3B
|
CAGR 3-Years
-37%
|
CAGR 5-Years
-35%
|
CAGR 10-Years
N/A
|
|
|
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
|
Operating Expenses
-¥1.1B
|
CAGR 3-Years
-19%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
-31%
|
|
|
Genscript Biotech Corp
HKEX:1548
|
Operating Expenses
-$797m
|
CAGR 3-Years
-20%
|
CAGR 5-Years
-40%
|
CAGR 10-Years
N/A
|
|
M
|
MGI Tech Co Ltd
SSE:688114
|
Operating Expenses
-¥2B
|
CAGR 3-Years
-47%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is WuXi Biologics (Cayman) Inc's Operating Expenses?
Operating Expenses
-2.7B
CNY
-2.7B
CNY
Based on the financial report for Dec 31, 2023, WuXi Biologics (Cayman) Inc's Operating Expenses amounts to -2.7B CNY.
What is WuXi Biologics (Cayman) Inc's Operating Expenses growth rate?
Operating Expenses CAGR 5Y
-53%
-53%
Over the last year, the Operating Expenses growth was -24%. The average annual Operating Expenses growth rates for WuXi Biologics (Cayman) Inc have been -45% over the past three years , -53% over the past five years .
You don't have any saved screeners yet
